Associate Professor David Preiss
David Preiss
PhD FRCPath MRCP
Associate Professor
- Honorary Consultant in Metabolic Medicine
MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit
David Preiss studied medicine at the University of Pretoria, South Africa, and qualified as a consultant in Chemical Pathology and Metabolic Medicine in 2012. He was appointed as a Senior Clinical Research Fellow at CTSU in September 2015. He completed his thesis, examining the links between glycaemia and cardiovascular disease, in 2011/2012 and was awarded the University of Glasgow’s Bellahouston Medal for this research. He was recipient of a Rising Star Fellowship from the European Foundation for the Study of Diabetes in 2013, and was also awarded the Royal College of Pathology’s Research Medal for Clinical Biochemistry in 2010.
His major interest is the prevention of cardiovascular disease with particular focus on lipid modification and diabetes. His current research combines clinical trials, epidemiological studies and meta-analyses of major studies. He is Chief Investigator for the NIHR funded LENS trial, a major streamlined study which is investigating the effect of the cholesterol-lowering drug, fenofibrate, on the progression of diabetic eye disease.
Key publications
-
Journal article
Sattar N. et al, (2016), Lancet Diabetes Endocrinol, 4, 403 - 410
-
Journal article
Preiss D. et al, (2015), Eur Heart J, 36, 1536 - 1546
-
Journal article
Swerdlow DI. et al, (2015), Lancet, 385, 351 - 361
-
Journal article
Preiss D. et al, (2014), The Lancet Diabetes and Endocrinology, 2, 116 - 124
-
Journal article
Preiss D. et al, (2011), JAMA, 305, 2556 - 2564
-
Journal article
Preiss D. et al, (2012), JAMA, 308, 804 - 811
Recent publications
-
Journal article
Kohli-Lynch CN. et al, (2022), Circulation
-
Impact of ACLY on type 2 diabetes in UK Biobank: a Mendelian randomisation study
Conference paper
Stiby A. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3011 - 3011
-
The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized controlled trials
Journal article
PREISS D. et al, (2021), Diabetes Care
-
Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009-2017
Conference paper
Thalmann I. et al, (2020), EUROPEAN HEART JOURNAL, 41, 3509 - 3509
-
Journal article
Herrington WG. et al, (2020), Clin Kidney J, 13